At the news
? NEUTRALIMPACT 2/10 6-K filed Jul 9, 2026 at 07:27 ET
GSK announced the appointment of Roy Jakobs, CEO of Royal Philips, as an independent Non-Executive Director effective July 13, 2026. This is a routine board addition bringing health technology expertise, with no material financial impact or strategic change.
- Roy Jakobs to join GSK board as independent Non-Executive Director from July 13, 2026
- Jakobs is currently CEO of Royal Philips (EUR 17.8B sales in 2025, 65,000 employees)
- Standard annual fee of £122,258 for the non-executive role
- Board expands to 13 members as of the effective date
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access